Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19
- Conditions
- Functional MRICognitive ImpairmentAstheniaCOVID-19
- Interventions
- Other: Structural and functional MRIDrug: Ethyl methyl hydroxypyridine succinate + MeldoniumDrug: Placebo
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT05939622
- Locations
- 🇷🇺
Federal State Budgetary Research Institution "Research Centre of Neurology", Moscow, Russian Federation
Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity
- Conditions
- Obesity
- Interventions
- Drug: metformin+sibutramine
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 240
- Registration Number
- NCT05821543
- Locations
- 🇷🇺
Ivanovo Clinical Hospital named after Kuvaev, Ivanovo, Russian Federation
🇷🇺Kirov State Medical University, Kirov, Russian Federation
🇷🇺Pirogov Russian National Research Medical University, Moscow, Russian Federation
Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 800
- Registration Number
- NCT05722691
- Locations
- 🇷🇺
Federal State Budgetary Educational Institution of Higher Education N. P. Ogarev Mordovia State University, Saransk, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of Ministry of Health of the Russian Federation, Kirov, Russian Federation
🇷🇺Professorskaya Klinika LLC, Perm, Russian Federation
Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19
- Conditions
- AstheniaCOVID-19
- Interventions
- Drug: Ethyl methyl hydroxypyridine succinate + MeldoniumDrug: Placebo
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 160
- Registration Number
- NCT05689827
- Locations
- 🇷🇺
Federal State Budgetary Research Institution "Research Centre of Neurology", Moscow, Russian Federation
🇷🇺OsteoVita LLC, Saint Petersburg, Russian Federation
🇷🇺Saint Petersburg State Budgetary Healthcare Institution "Municipal Hospital No. 40 of Kurortny District", Sestroretsk, Russian Federation
Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19
- Conditions
- COVID-19
- Interventions
- Drug: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate inhaledDrug: Standard of careDrug: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 313
- Registration Number
- NCT05656495
- Locations
- 🇷🇺
Ryazan State Medical University named after academician I.P. Pavlov of Ministry of Health of the Russian Federation, Ryazan, Russian Federation
🇷🇺Voronezh Regional Clinical Hospital No.1, Voronezh, Russian Federation
🇷🇺Infectious Clinical Hospital No.1, Moscow, Russian Federation
Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 264
- Registration Number
- NCT05601167
- Locations
- 🇷🇺
Regional Budgetary Healthcare Institution "Ivanovo Clinical Hospital", Ivanovo, Russian Federation
🇷🇺Kirov State Medical University of Ministry of Health of the Russian Federation, Kirov, Russian Federation
🇷🇺Avrora MedFort, LLC, Saint Petersburg, Russian Federation
Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19
- Conditions
- COVID-19
- Interventions
- Drug: Molnupiravir (Esperavir)Drug: Standard of care
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 240
- Registration Number
- NCT05595824
- Locations
- 🇷🇺
Regional Budget Healthcare Institution "Ivanovo clinical hospital", Ivanovo, Russian Federation
🇷🇺Kirov State Medical University of Ministry of Health of the Russian Federation, Kirov, Russian Federation
🇷🇺State Budgetary Healthcare Institution City Clinical Hospital named after S. I. Spasokukotskiy of Moscow Healthcare Department, Moscow, Russian Federation
Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 217
- Registration Number
- NCT05185284
- Locations
- 🇷🇺
Regional Clinic Hospital of Ryazan, Ryazan', Russian Federation
🇷🇺Smolensk clinical hospital №1, Smolensk, Russian Federation
🇷🇺State Clinical Hospital №50, Moscow, Russian Federation
Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 200
- Registration Number
- NCT04542694
- Locations
- 🇷🇺
City Hospital N40 of Kurortny District, Saint Petersburg, Russian Federation
🇷🇺Regional Clinic Hospital of Ryazan, Ryazan', Russian Federation
🇷🇺Smolensk clinical hospital №1, Smolensk, Russian Federation
The PRIMAVERA Study: Reduxine Safety Monitoring in Patients With Alimentary Obesity
- Conditions
- Alimentary Obesity
- First Posted Date
- 2013-01-23
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Promomed, LLC
- Target Recruit Count
- 98774
- Registration Number
- NCT01773733